Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

Mechanism of action of complex molecules rationally designed to target multiple adverse signaling pathways in tumor cells

EF 2012-13

Résumé
With a better understanding of signaling pathways functionally deregulated in human cancers, a lot of progress has been made in the field of targeted therapy. Cancer, especially in its advanced stages is extremely heterogenous and is controlled by a complex network of signaling molecules involved in synergistic cross-talk and redundancy. In trying to address this challenging issue, we designed and synthesized drugs capable of releasing potent inhibitors of tyrosine kinases (EGFR, c-Src, c-MET) often overexpressed in cancers. The aim of my project is to assess the ability of these drugs in blocking proliferation, invasion, migration as well as inducing apoptosis in tumor cell lines. Through this approach, we wish to develop single molecules that are capable of potently inhibiting two or more kinases, thereby eliminating the need to use multiple drugs, to achieve similar outcome.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
283994
Name
Rao Suman
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Mechanism of action of complex molecules rationally designed to target multiple adverse signaling pathways in tumor cells
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
C-Met; C-Src; Cancer; Combi-Targeting Drugs; Epidermal Growth Factor Receptor; Receptor Tyrosine Kinases; Signal Transduction Pathways
Abstract
With a better understanding of signaling pathways functionally deregulated in human cancers, a lot of progress has been made in the field of targeted therapy. Cancer, especially in its advanced stages is extremely heterogenous and is controlled by a complex network of signaling molecules involved in synergistic cross-talk and redundancy. In trying to address this challenging issue, we designed and synthesized drugs capable of releasing potent inhibitors of tyrosine kinases (EGFR, c-Src, c-MET) often overexpressed in cancers. The aim of my project is to assess the ability of these drugs in blocking proliferation, invasion, migration as well as inducing apoptosis in tumor cell lines. Through this approach, we wish to develop single molecules that are capable of potently inhibiting two or more kinases, thereby eliminating the need to use multiple drugs, to achieve similar outcome.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Rao, Suman
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~